Torrent Pharmaceuticals Limited has informed the Exchange about Investor Presentation

28th July, 2025

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1st Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

The Manager – Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Presentation to analysts on unaudited Consolidated Financial Results for the quarter

ended 30th June, 2025

The presentation on unaudited Consolidated Financial Results for the quarter ended 30th June, 2025 to be made to analysts is enclosed for your records.

Thanking you,

Yours Sincerely,

For TORRENT PHARMACEUTICALS LIMITED

CHINTAN M. TRIVEDI COMPANY SECRETARY

Encl: A/a

___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED CIN: L24230GJ1972PLC002126 Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com

Q1 FY 2025-26

Revenues: Summary

1

Revenue: Summary

Revenues (Rs cr)

Q1 FY26

Q1 FY25

India

United States

Germany

Brazil

Others

Total

1,811

1,635

308

308

218

533

259

284

196

485

3,178

2,859

Gr%

11%

19%

9%

11%

10%

11%

2